Compare FCEL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCEL | AORT |
|---|---|---|
| Founded | 1969 | 1984 |
| Country | United States | United States |
| Employees | 629 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 1996 |
| Metric | FCEL | AORT |
|---|---|---|
| Price | $20.05 | $27.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.31 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 9.6M | 550.4K |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $4.77 | $14.20 |
| Revenue Next Year | $42.46 | $11.20 |
| P/E Ratio | ★ N/A | $886.00 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $3.78 | $19.16 |
| 52 Week High | $37.88 | $48.25 |
| Indicator | FCEL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 57.36 |
| Support Level | $16.99 | $19.49 |
| Resistance Level | $26.39 | $37.65 |
| Average True Range (ATR) | 2.46 | 0.95 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 30.22 | 54.28 |
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.